Toxicity reduction of existing drugs
A composition containing resveratrol, a tuberculostatic agent, and a pharmaceutically acceptable carrier has been claimed in a patent application[1] which prevents and/or reduces hepatotoxicity associated with a treatment for tuberculosis, reduces the duration of the treatment and avoids the creation of resistant Mycobacterium tuberculosis strains.
Key Words: multidrug resistant tuberculosis, extensively drug resistant tuberculosis, multidrug resistant TB, extensively drug resistant TB, MDR TB, XDR TB, mycobacterium tuberculosis, mycobacterial infection, literature, research, publications, patents.
A composition containing resveratrol, a tuberculostatic agent, and a pharmaceutically acceptable carrier has been claimed in a patent application[1] which prevents and/or reduces hepatotoxicity associated with a treatment for tuberculosis, reduces the duration of the treatment and avoids the creation of resistant Mycobacterium tuberculosis strains.
Key Words: multidrug resistant tuberculosis, extensively drug resistant tuberculosis, multidrug resistant TB, extensively drug resistant TB, MDR TB, XDR TB, mycobacterium tuberculosis, mycobacterial infection, literature, research, publications, patents.
No comments:
Post a Comment